Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer

Original Article

Y.-L. Wu, M. Hochmair, Y. Yang, X.-N. Yang, M. Tsuboi, L. Paz-Ares, J.C.-H. Yang, L. Wu, H.R. Kim, D.T. Rieke, M. Johnson, B. Besse, N. Sharma, P. Maeda, P. Peterson, B.K. Lin, B. Frimodt-Moller, J. Goldman, and A. Drilon

N Engl J Med 2026;395:660-670

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/12/2026
Course expires: 
08/13/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.